参考文献/References:
[1]Caiazza F,Ryan EJ,Doherty G,et al.Estrogen receptors and their implications in colorectal carcinogenesis[J].Front Oncol,2015(5):19-28.[2]Caiazza F,Ryan EJ,Doherty G,et al.Estrogen receptors and their implications in colorectal carcinogenesis[J].Front Oncol,2015(5):19.[3]胡春梅.人表皮生长因子受体-2和Ki-67及雌孕激素受体在男性乳腺癌中的表达及意义[J].中华实用诊断与治疗杂志,2016(12):1213-1214. [4]李颖.雌激素对乳腺癌CD147表达的调节及在乳腺正常发育和乳腺癌进展转移中的意义[D].第四军医大学,2012.[5]赖俊清.雌激素或避孕药治疗青春期功能性子宫出血的效果观察[J].实用妇科内分泌杂志,2017,4(15):40-41.[6]张智虹,王星.雌激素局部与全身序贯应用治疗老年性阴道炎的临床观察[J].中国临床医生杂志,2020,48(2):216-220.[7]Zhang Y,Yan W,Ge PF,et al.Study on prevention effect of Zishen Yutai pill combined with progesterone for threatened abortion in rats[J].Asian Pac J Trop Med,2016,9(6):577-581.[8]聂磊.探讨孕早期血清雌二醇、孕酮及人绒毛促性腺激素水平预测在先兆流产诊断中的应用价值[J].中国妇幼保健,2017,32(1):110-112.[9]张雪华.血清雌二醇水平对早期先兆流产预后的预测价值[J].实用临床医药杂志,2016,20(11):198-200.[10]温燕逖,刘桂英.小剂量戊酸雌二醇联合坤泰胶囊治疗围绝经期综合征30例临床观察[J].北方药学,2015,12(6):102-104.[11]Laresgoiti-Servitje E,Gómez-López N,Olson DM.An immunological insight into the origins of pre-eclampsia[J].Hum Reprod Update,2010,16(5):510-524.[12]Hsu P,Nanan RK.Innate and adaptive immune interactions at the fetal-matemal interface in healthy human pregnancy and pre-eclampsia[J].Front Immunol,2014(5):125.[13]Hong L,Krishnamachari Y,Seabold D,et al.Intracellular release of 17-β estradiol from cationic polyamidoamine dendrimer surface-modified poly (lactic-co-glycolic acid) microparticles improves osteogenic differentiation of human mesenchymal stromal cells[J].Tissue Eng Part C Methods,2011,17(3):319-325.[14]Beyer C,Zampetaki A,Lin NY,et al.Signature of circulating microRNAs in osteoarthritis[J].Annals of the Rheumatic Diseases,2015,74(3):e18.[15]Chim SS,Shing TK,Hung EC,et al.Detection and characterization of placental microRNAs in maternal plasma[J].Clin Chem,2008,54(3):482-490.[16]Wang Y,Fan H,Zhao G,et al.miR-16 inhibits the proliferation and angiogenesis-regulating potential of mesenchymal stem cells in severe pre-eclampsia[J].FEBS J,2012,279(24):4510-4524.[17]Xu P,Zhao Y,Liu M,et al.Variations of microRNAs in human placentas and plasma from preeclamptic pregnancy[J].Hypertension,2014,63(6):1276-1284.[18]张颖,赵光锋,李洁.雌二醇通过ERα抑制miR-16表达并促进蜕膜间充质干细胞生长[J].中国病理生理杂志,2017,33(12):2227-2232. [19]叶蔚,王明蕊,范可心,等.雌、孕激素和血管内皮生长因子在子痫前期胎盘中的表达[J].生殖医学杂志,2015,24(11):938-941.[20]Babic GM,Markovic SD,Varjacic M,et al.Estradiol decreases blood pressure in association with redox regulation in preeclampsia[J].Clin Exp Hypertens,2018,40(3):281-286.[21]Chen YC,Lai YJ,Su YT,et al.Higher gestational weight gain and lower serum estradiol levels are associated with increased risk of preeclampsia after in vitro fertilization[J].Pregnancy Hypertens,2020(22):126-131.[22]黄丽琼,郑波,张元珍,等.2-甲氧雌二醇在早发型子痫前期患者中的表达及临床意义[J].陕西医学杂志,2019,48(2):208-212.[23]陈霏,王碧.血清游离雌三醇和脂联素水平与妊娠糖尿病孕晚期发生胎儿窘迫的相关性研究[J].现代检验医学杂志,2019,34(6):101-104.[24]徐东魁,禹晓冰,高芳.血清肿瘤坏死因子-α和游离雌三醇水平在妊娠高血压患者中的表达及临床意义[J].解放军医药杂志,2019,31(9):69-72.[25]张焕改,郭玮,谷惠芳,等.孕母妊娠高血压对新生儿多系统的影响[J].临床儿科杂志,2014,32(11):1042-1047.[26]顾秀兰.雌三醇及胎盘催乳素检测对胎儿生长受限的意义[J].国际检验医学杂志,2016,37(8):1060-1061.[27]于彩霞,王会芳,胡哲英.探讨血清雌三醇和人胎盘催乳素水平与高危妊娠的关系[J].解放军医学院学报,2014,35(2):150-152.[28]卢帅军,厉倩,朱长玲,等.妊娠母体血清hPL、Ue3水平与子痫前期的关系[J].周际检验医学杂志,2012,33(13):1574-1575．[29]武丽红,张斌斌,黄玲聪.PAPP-A、Netrin-1、PP13及雌三醇水平对胎儿生长受限的预测价值[J].中国微生态学杂志,2018,30(4):99-101.[30]付久园,肖艳平,王红杰,等.唐氏综合征产前血清标记物筛查的探讨[J].河北医学,2017,23(12):2010-2013.[31]张丽霞,罗雅丽,余文友.孕中期血清绒毛膜促性腺激素甲胎蛋白及游离雌三醇水平联合检测筛查唐氏综合征的效果观察[J].实用医技杂志,2020,27(1):55-57.[32]洪秀,盛晓园.早产发生率及高危因素及对围产结局的影响[J].中国医院统计,2019,26(3):218-221.[33]Vohr B.Long-term outcomes of moderately preterm,late preterm,and early term infants[J].Clin Perinatol,2013(40):739-751.[34]曾筱安,李九凤,邓国宝,等.测定孕妇唾液中游离雌三醇含量预测早产的发生[J].中国优生与遗传杂志,2010(2):69-70.[35]Nunthapiwat S,Sekararithi R,Wanapirak C,et al.Second Trimester Serum Biomarker Screen for Fetal Aneuploidies as a Predictor of Preterm Delivery: A Population-Based Study[J].Gynecol Obstet Invest,2019,84(4):326-333.[36]朱云花,刘胜兰,夏元旦.血清游离雌三醇测定用于判断胎儿宫内状况的临床研究[J].浙江创伤外科,2019,24(3):505-506.[37]Apter D,Zimmerman Y,Beekman L,et al.Estetrol combined with drospirenone: an oral contraceptive with high acceptability, user satisfaction, well-being and favourable body weight control[J].Eur J Contracept Reprod Health Care,2017,22(4):260-267.[38]Valéra MC,Noirrit-Esclassan E,Dupuis M,et al.Effect of estetrol, a selective nuclear estrogen receptor modulator, in mouse models of arterial and venous thrombosis[J].Mol Cell Endocrinol,2018(477):132-139.[39]黎杨坚,李燕姬,伦妙容.妊娠期血清雌激素和孕激素水平的变化及其与胎儿宫内发育情况的关系[J].实用医技杂志,2019,26(5):564-565.[40]Palazzo C,Laloy J,Delvigne AS,et al.Development of injectable liposomes and drug-in-cyclodextrin-in-liposome formulations encapsulating estetrol to prevent cerebral ischemia of premature babies[J].Eur J Pharm Sci,2019(127):52-59.[41]Gaspard U,Taziaux M,Mawet M,et al.A multicenter, randomized study to select the minimum effective dose of estetrol (E4) in postmenopausal women (E4Relief): part 1. Vasomotor symptoms and overall safety[J].Menopause,2020,27(8):848-857.[42]Holinka CF,Brincat M,Coelingh Bennink HJ.Preventive effect of oral estetrol in a menopausal hot flush model[J].Climacteric,2008,11(Suppl 1):15-21.[43]苏婷,宋殿荣,郭洁,等.不同绝经时期妇女雌激素受体亚型在阴道组织中的表达[J].天津中医药,2019(6):595-598.[44]Fernandez SV,Russo IH,Russo J.Estradiol and its metabolites 4-hydroxyestradiol and 2-hydroxyestradiol induce mutations in human breast epithelial cells[J].Int J Cancer,2006,118(8):1862-1868.[45]Totland MZ,Rasmussen NL,Knudsen LM,et al.Regulation of gap junction intercellular communication by connexin ubiquitination: physiological and pathophysiological implications[J].Cell Mol Life Sci,2020,77(4):573-591.[46]唐雪莲,谢梅青,赵晓苗,等.雌二醇及雌酮对人子宫内膜细胞GJIC及连接蛋白的影响[J].中山大学学报(医学科学版),2013,34(3):345-350.[47]Leone S,Busonero C,Acconcia F.A high throughput method to study the physiology of E2:ERα signaling in breast cancer cells[J].J Cell Physiol,2017,37(9):1125-1327.[48]王景,张鹤达,李建,等.Smad1参与调节雌激素在乳腺癌细胞中的促增殖作用[J].中国临床医学,2016,23(2):144-148.[49]Ye Y,Xiao Y,Wang W,et al.ERalpha signaling through slug regulates E-cadherin and EMT[J].Oncogene,2010,29(10):1451-1462.[50]Bugide S,David D,Nair A,et al.Hematopoietic PBX-interacting protein (HPIP) is over expressed in breast infiltrative ductal carcinoma and regulates cell adhesion and migration through modulation of focal adhesion dynamics[J].Oncogene,2015,34(35):4601-4612.[51]武春兰,李阳,刘晓红,等.雌二醇通过钙离子/钙激活中性蛋白酶通路诱导乳腺癌细胞迁移及FAK蛋白剪切[J].肿瘤防治研究,2012,39(9):1041-1045.[52]Tajbakhsh A,Pasdar A,Rezaee M,et al.The current status and perspectives regarding the clinical implication of intracellular calcium in breast cancer[J].J Cell Physiol,2018,233(8):5623-5641.[53]Yousif NG.Fibronectin promotes migration and invasion of ovarian cancer cells through up-regulation of FAK-PI3K/Akt pathway[J].Cell Biol Int,2014,38(1):85-91.[54]龚琳,郑莹,刘珊玲,等.纤维连接蛋白在卵巢癌多细胞团簇中的作用和顺铂对团簇的影响[J].实用妇产科杂志,2018,34(12):930-934.[55]余庆龙,张莹,王宏健,等.17β-雌二醇对乳腺癌细胞迁移的影响及CANP-FN通路的介导作用[J].中国药理学通报,2017,33(10):1371-1376.[56]Gao Y,Wang Z,Hao Q,et al.Loss of ERα induces amoeboid-like migration of breast cancer cells by downregulating vinculin[J].Nat Commun,2017(8):14483.[57]Larionov AA,Miller WR.Challenges in defining predictive markers for response to endocrine therapy in breast cancer[J].Future Oncol,2009,5(9):1415-1428.[58]Shagufta,Ahmad I.Tamoxifen a pioneering drug: An update on the therapeutic potential of tamoxifen derivatives[J].Eur J Med Chem,2018(143):515-531.[59]Yu T,Liu M,Luo H,et al.GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells[J].J Steroid Biochem Mol Biol,2014(143):392-403.[60]Kodahl AR,Lyng MB,Binder H,et al.Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study[J].Mol Oncol,2014,8(5):874-883.[61]Tan S,Ding K,Li R,et al.Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2[J].Breast Cancer Res,2014,16(2):R40.[62]曾超.浸润性乳腺癌中14-3-3σ蛋白的表达与ER,PR的相关性研究[J].中国医药导报,2015(12):90-93.[63]Romero-Cordoba SL,Rodriguez-Cuevas S,Bautista-Pina V,et al.Loss of function of miR-342-3p results in MCT1 over-expression and contributes to oncogenic metabolic reprogramming in triple negative breast cancer[J].Sci Rep,2018,8(1):12252.[64]Cittelly DM,Das PM,Spoelstra NS,et al.Downregulation of miR-342 is associated with tamoxifen resistant breast tumors[J].Mol Cancer,2010(9):317.[65]Lee YM,Lee JY,Ho CC,et al.miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells[J].Breast Cancer Res,2011,13(6):R116.
相似文献/References:
[1]董 云.SPECT/CT 双时相99mTc- MIBI断层显像
在乳腺癌诊断中的应用[J].医学信息,2018,31(05):147.[doi:10.3969/j.issn.1006-1959.2018.05.053]
DONG Yun.Application of SPECT/CT Dual-phase 99mTc-MIBI Tomography in the Diagnosis of Breast Cancer[J].Medical Information,2018,31(10):147.[doi:10.3969/j.issn.1006-1959.2018.05.053]
[2]李建辉,祝旭龙.乳腺癌的治疗管理——把好生活质量关[J].医学信息,2018,31(13):1.[doi:10.3969/j.issn.1006-1959.2018.13.001]
[3]杨玉峰,李 强,曲国红,等.乳腺癌术前巴德枪穿刺检测ER、PR的临床研究[J].医学信息,2018,31(13):163.[doi:10.3969/j.issn.1006-1959.2018.13.050]
YANG Yu-feng,LI Qiang,QU Guo-hong,et al.Clinical Study on Preoperative ER and PR Detection of Bard Gun Puncture in Breast Cancer[J].Medical Information,2018,31(10):163.[doi:10.3969/j.issn.1006-1959.2018.13.050]
[4]刘 曼,厉玛倩倩,徐润润,等.延续性护理对乳腺癌术后化疗患者生活质量与
健康知识水平的影响[J].医学信息,2018,31(16):178.[doi:10.3969/j.issn.1006-1959.2018.16.057]
LIU Man,LIMA Qian-qian,XU Run-run,et al.Effect of Continuous Nursing on Quality of Life and Health Knowledge of Postoperative Chemotherapy Patients with Breast Cancer[J].Medical Information,2018,31(10):178.[doi:10.3969/j.issn.1006-1959.2018.16.057]
[5]张艳萍,曹 玉,孙国平.服用阿司匹林对乳腺癌患者生存获益的Meta分析[J].医学信息,2018,31(20):72.[doi:10.3969/j.issn.1006-1959.2018.20.021]
ZHANG Yan-ping,CAO Yu,SUN Guo-ping.Meta Analysis of the Survival Benefit of Patients with Breast Cancer Treated with Aspirin[J].Medical Information,2018,31(10):72.[doi:10.3969/j.issn.1006-1959.2018.20.021]
[6]钟 磊,谢海燕,林 霖.电化学发光免疫分析技术检测肿瘤标志物在乳腺癌诊断中的应用[J].医学信息,2018,31(20):155.[doi:10.3969/j.issn.1006-1959.2018.20.048]
ZHONG Lei,XIE Hai-yan,LIN Lin.Application of Electrochemiluminescence Immunoassay for Detection of Tumor Markers in Diagnosis of Breast Cancer[J].Medical Information,2018,31(10):155.[doi:10.3969/j.issn.1006-1959.2018.20.048]
[7]胡平华,黄 勤,李志华.含卡培他滨方案一线或后线治疗晚期乳腺癌的效果对比[J].医学信息,2018,31(22):142.[doi:10.3969/j.issn.1006-1959.2018.22.041]
HU Ping-hua,HUANG Qin,LI Zhi-hua.Comparison of the Efficacy of Capecitabine Regimen in the Treatment of Advanced Breast Cancer with First-line or Posterior Line Therapy[J].Medical Information,2018,31(10):142.[doi:10.3969/j.issn.1006-1959.2018.22.041]
[8]阙海涛,曹 斌,秦志刚.EGFL7在乳腺癌中的研究进展[J].医学信息,2018,31(23):32.[doi:10.3969/j.issn.1006-1959.2018.23.010]
QUE Hai-tao,CAO Bin,QIN Zhi-gang.Research Progress of EGFL7 in Breast Cancer[J].Medical Information,2018,31(10):32.[doi:10.3969/j.issn.1006-1959.2018.23.010]
[9]张文婧,宋 冰.HER-2阳性乳腺癌分子靶向治疗进展[J].医学信息,2018,31(24):42.[doi:10.3969/j.issn.1006-1959.2018.24.012]
ZHANG Wen-jing,SONG Bing.Progress in Molecular Targeted Therapy for HER-2 Positive Breast Cancer[J].Medical Information,2018,31(10):42.[doi:10.3969/j.issn.1006-1959.2018.24.012]
[10]张 乐,徐胜昔,郭翔取,等.Tyrer-Cuzick模型联合SNPs位点在江西地区乳腺癌诊断中应用研究[J].医学信息,2018,31(24):131.[doi:10.3969/j.issn.1006-1959.2018.24.038]
ZHANG Le,XU Sheng-xi,GUO Xiang-qu,et al.Application of Tyrer-Cuzick Model Combined with SNPs Locus in the Diagnosis of Breast Cancer in Jiangxi Area[J].Medical Information,2018,31(10):131.[doi:10.3969/j.issn.1006-1959.2018.24.038]